High drug prices frustrate government-sponsored health programs; report

Health plans partnering with Express Scripts are delivering high-quality, affordable pharmacy care to millions of individuals enrolled in government-sponsored programs, but this record is at risk without decisive action to advance additional pro-patient and pro-payer policy changes, according to new research released today by Express Scripts (Nasdaq: ESRX), the largest pharmacy benefit management organization in the USA.

"Our country is engaged in an important dialogue about how best to provide millions of Americans with much needed pharmacy care, and how to deliver that care in the most affordable and sustainable way," said Glen Stettin, chief innovation officer at Express Scripts. "While the health plans entrusted with implementing these programs are, overall, managing pharmacy costs effectively, Express Scripts has identified additional areas where policymakers should act now to curb high drug prices and reduce wasteful spending," Dr Stettin added.

Top-line findings